Disease patterns and survival rate in children with metastatic soft‐tissue sarcoma: A report from the intergroup rhabdomyosarcoma study (IRS)‐I

Cancer

Volumn 62, Issue 7, 1988, Pages 1257-1266

  Raney, R Beverly ^a   Tefft, Melvin ^a   Maurer, Harold M ^b   Ragab, Abdelsalam H ^b   Hays, Daniel M ^a   Soule, Edward H ^a   Foulkes, Mary A ^c   Gehan, Edmund A ^c  

^a Children's Cancer Study Group ^*  (United States)

^b Children's Oncology Group   (United States)

^c Pediat Intergroup Stat Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADOLESCENT; AGE; CANCER RECURRENCE; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023802422     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19881001)62:7<1257::AID-CNCR2820620703>3.0.CO;2-K     Document Type: Article

References (26)

1. The Intergroup Rhabdomyosarcoma Study: A preliminary report
2. The Intergroup Rhabdomyosarcoma Study‐I: A final report
3. Extraskeletal Ewing's sarcoma: A preliminary review of 26 cases encountered in the Intergroup Rhabdomyosarcoma Study
4. A generalized Wilcoxon test for comparing arbitrarily singly‐censored samples
5. Rhabdomyosarcoma of the ear in childhood: A report from the Intergroup Rhabdomyosarcoma Study‐I
6. Prognosis of children with soft‐tissue sarcoma who relapse after achieving a complete response
7. The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children
8. The influence of chemotherapy on the prognosis of rhabdomyosarcoma
9. Multidisciplinary treatment of embryonal rhabdomyosarcoma in children
10. Treatment of rhabdomyosarcoma in children with surgery, radiotherapy and chemotherapy
11. Prognosis in children with metastatic rhabdomyosarcoma
12. Soft‐tissue sarcomas in the young: Medical treatment advances in perspective
13. Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962–1978
14. Multidisciplinary treatment of advanced stages of embryonal rhabdomyosarcoma in children
15. The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma: A historical comparison of 345 patients in the same center
16. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (Clinical Groups III and IV)
17. The Intergroup Rhabdomyosarcoma Study II: Objectives and study design
18. Intergroup Rhabdomyosarcoma Study (IRS)‐II: Preliminary report (Abstr C‐274)
19. Phase II trial of cisplatin in refractory childhood cancer: Children's Cancer Study Group report
20. Phase II study of VP‐16–213 in childhood malignant disease: A Children's Cancer Study Group report
21. Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma
22. Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: A report from the Italian Cooperative Rhabdomyosarcoma Group
23. Ifosfamide with Mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults
24. Methotrexate as relapse therapy for rhabdomyosarcoma
25. Multi‐agent chemotherapy with adjuvant whole‐body irradiation in half‐body increments in patients with Clinical Group IV rhabdomyosarcoma (RMS) and extra‐osseous Ewing's sarcoma (Abstr)
26. Treatment of high‐risk sarcomas with an intensive consolidation followed by autologous bone marrow transplantation (Abstr no. 859)